Chana Weinstock
6PUBLICATIONS
42CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 12, 2026
FDA Approval Summary: Durvalumab for the Treatment of Adult Patients with Muscle-Invasive Bladder Cancer.Nooshin Mirkheshti, Daniel Edem Kpormegbey, Chana Weinstock
|Sep 09, 2024
FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma.Jaleh Fallah, Brian L Heiss, Hee-Koung Joeng
|Sep 04, 2024
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma.Michael H Brave, William F Maguire, Chana Weinstock
|Mar 05, 2024
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma.William F Maguire, Daniel Lee, Chana Weinstock
|Feb 28, 2024
A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma.Elaine Chang, Jiaxi Zhou, Chi Song
|Feb 01, 2023
FDA Approval Summary: Belzutifan for VHL Disease Tumors-Response.Jaleh Fallah, Chana Weinstock, Gautam U Mehta
Pageof 1
Frequent Collaborators
6 joint publications
Richard Pazdur
6 joint publications
Daniel L Suzman
6 joint publications
Laleh Amiri-Kordestani
4 joint publications
Xin Gao
4 joint publications
William F Pierce
4 joint publications
Paul G Kluetz
3 joint publications
Elaine Chang
3 joint publications
Shenghui Tang
3 joint publications
Mallorie H Fiero
2 joint publications
Michael H Brave
